Halvorsen Peder Andreas, Kristiansen Ivar Sønbø, Aasland Olaf Gjerløw, Førde Olav Helge
Institute of Community Medicine, University of Tromsø, Tromsø, Norway.
Scand J Prim Health Care. 2003 Sep;21(3):162-6. doi: 10.1080/02813430310001158.
While the number needed to treat (NNT) is in widespread use, empirical evidence that doctors or patients interpret the NNT adequately is sparse. The aim of our study was to explore the influence of the NNT on medical doctors' recommendation for or against a life-long preventive drug therapy.
Cross-sectional study with randomisation to different scenarios.
Postal questionnaire presenting a clinical scenario about a hypothetical drug as a strategy towards preventing premature death among healthy people with a known risk factor. Benefit after 5 years of treatment was presented in terms of NNT, which was set at 50 for half of the respondents and 200 for the other half.
Representative sample (n = 1616) of Norwegian medical doctors.
Proportion of doctors that would prescribe the drug. Reasons for recommending against the therapy.
With NNT set at 50, 71.6% (99% CI 66.8-76.4) of the doctors would prescribe the drug, while the proportion was 52.3% (99% CI 47.5-57.1) with an NNT of 200 (chi = 50.7, p < 0.001). Multivariate logistic regression analysis indicated that the effect of NNT on the likelihood for recommending the therapy was age-dependent; young doctors ( < 36 of age) were more sensitive to the difference in NNTs than older doctors. Thirty-six percent (n = 464) of the doctors would not prescribe the drug, and 77.4% (99% CI 68.5-86.2) of those agreed with an argument stating that only one out of NNT patients would benefit from the treatment.
Medical doctors appear to be sensitive to the magnitude of the NNT in their clinical recommendations. However, many doctors believe that only one out of NNT patients benefits from therapy. Clinical recommendations based on this assumption may be misleading.
虽然需治疗人数(NNT)被广泛使用,但关于医生或患者能否充分理解NNT的实证证据却很少。我们研究的目的是探讨NNT对医生推荐或反对终身预防性药物治疗的影响。
采用随机分配至不同场景的横断面研究。
通过邮政问卷呈现一个关于一种假设药物的临床场景,该药物作为预防具有已知风险因素的健康人过早死亡的策略。以NNT来表示5年治疗后的益处,对一半的受访者设定NNT为50,对另一半设定为200。
挪威医生的代表性样本(n = 1616)。
会开具该药物的医生比例。反对该治疗的原因。
当NNT设定为50时,71.6%(99%可信区间66.8 - 76.4)的医生会开具该药物,而当NNT为200时,这一比例为52.3%(99%可信区间47.5 - 57.1)(χ² = 50.7,p < 0.001)。多因素逻辑回归分析表明,NNT对推荐治疗可能性的影响取决于年龄;年轻医生(年龄<36岁)比年长医生对NNT差异更敏感。36%(n = 464)的医生不会开具该药物,其中77.4%(99%可信区间68.5 - 86.2)同意这样一种观点,即NNT患者中只有一人会从治疗中获益。
医生在临床推荐中似乎对NNT的大小很敏感。然而,许多医生认为NNT患者中只有一人能从治疗中获益。基于这一假设的临床推荐可能会产生误导。